The aberrant expression of β-catenin gene (CTNNB1) is commonly observed in ovarian carcinoma, it is an important molecular marker which promotes ovarian cancer progression via diverse mechanisms including gene mutations or non-genetic mutation fashions in the presence of extracellular inhibitors and intranuclear transcription cofactors [68–70]. The gene discussed is CTNNB1; the disease is ovarian carcinoma.